Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last kr375.00 DKK
Change Today 0.00 / 0.00%
Volume 213.2K
CHR On Other Exchanges
Symbol
Exchange
Copenhagen
OTC US
OTC US
Frankfurt
As of 11:04 AM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

chr hansen holding a/s (CHR) Snapshot

Open
kr373.90
Previous Close
kr375.00
Day High
kr375.20
Day Low
kr371.90
52 Week High
07/20/15 - kr387.90
52 Week Low
10/16/14 - kr198.74
Market Cap
49.4B
Average Volume 10 Days
255.5K
EPS TTM
kr1.15
Shares Outstanding
131.9M
EX-Date
07/7/15
P/E TM
43.7x
Dividend
kr3.77
Dividend Yield
2.76%
Current Stock Chart for CHR HANSEN HOLDING A/S (CHR)

Related News

No related news articles were found.

chr hansen holding a/s (CHR) Related Businessweek News

No Related Businessweek News Found

chr hansen holding a/s (CHR) Details

Chr. Hansen Holding A/S, a bioscience company, develops and sells natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries. The company’s Cultures and Enzymes division produces and sells cultures, enzymes, and probiotic products that determine the taste, flavor, color, texture, safety, preservation, nutritional value, and health benefits of various consumer products in the food and dairy industries. Its Health and Nutrition division provides probiotic cultures for the dietary supplement, over-the-counter pharmaceutical, infant formula, and animal feed and plant protection industries. The company’s Natural Colors division offers natural color solutions for the food industries, primarily including the beverage, confectionery, ice cream, dairy, fruit preparation, and prepared food segments. It has strategic alliance with FMC Corporation for development and commercialization of biological plant protection products. The company operates in Europe, the Middle East, Africa, North and South America, and the Asia Pacific. Chr. Hansen Holding A/S was founded in 1874 and is headquartered in Hørsholm, Denmark.

2,500 Employees
Last Reported Date: 07/1/15
Founded in 1874

chr hansen holding a/s (CHR) Top Compensated Officers

Chief Executive Officer, President and Member...
Total Annual Compensation: €890.0K
Executive Vice President of Cultures & Enzyme...
Total Annual Compensation: €620.0K
Compensation as of Fiscal Year 2014.

chr hansen holding a/s (CHR) Key Developments

Søren Westh Lonning Joins as New Chief Financial Officer and Member of the Executive Board of Chr. Hansen Holding A/S, effective August 1, 2015

Søren Westh Lonning has been appointed the new Chief Financial Officer (CFO) and member of the Executive Board of Chr. Hansen Holding A/S. Søren Westh Lonning is currently Managing Director with responsibility for South West Europe and Vice President Finance for the EMEA region at Chr. Hansen. Søren will take up his new position on August 1, 2015.

Chr. Hansen Holding A/S Announces Consolidated Earnings Results for the Third Quarter and Nine Months Ended May 31, 2015; Reaffirms Earnings Guidance for the Fiscal Year 2015

Chr. Hansen Holding A/S announced consolidated earnings results for the third quarter and nine months ended May 31, 2015. For the quarter, revenue was EUR 228.1 million against EUR 198.1 million a year ago. Operating profit (EBIT) was EUR 63.8 million against EUR 54.3 million a year ago. Profit before tax was EUR 61.7 million against EUR 51.1 million a year ago. Profit for the period attributable to shareholders of the company was EUR 45.7 million against EUR 37.4 million a year ago. Basic and diluted earnings per share from continuing operations were EUR 0.35 against EUR 0.28 a year ago. Free cash flow EUR 53.8 million, compared to EUR 40.5 million last year. EBITDA was EUR 77.3 million against EUR 67.8 million a year ago. EBIT before special items was EUR 63.8 million against EUR 55.0 million a year ago. Cash flow from operating activities was EUR 71.6 million against EUR 54.7 million a year ago. Revenues were up 15% from last year, of course, backed to some extent by currencies. For the year to date, revenue was EUR 625.0 million against EUR 550.9 million a year ago. Operating profit (EBIT) was EUR 159.8 million against EUR 138.5 million a year ago. Profit before tax was EUR 149.9 million against EUR 128.2 million a year ago. Profit for the period attributable to shareholders of the company was EUR 111.0 million against EUR 93.7 million a year ago. Basic and diluted earnings per share from continuing operations were EUR 0.85 against EUR 0.70 a year ago. Free cash flow was EUR 65.0 million, compared to EUR 41.8 million a year ago. EBITDA was EUR 200.5 million against EUR 181.5 million a year ago. EBIT before special items was EUR 159.8 million against EUR 143.2 million a year ago. Cash flow from operating activities was EUR 110.6 million against EUR 82.3 million a year ago. Net interest-bearing debt was EUR 437.6 million against EUR 438.5 million a year ago. The operating profit increased by 12%, and that was driven by the solid organic growth and the stronger U.S. dollar. The company reaffirmed its earnings guidance for the fiscal year 2015. For the year, the performance in the first nine months of 2014/15 was encouraging with good progress across divisions and strategic initiatives. Based on this the company have narrowed its organic revenue expectations for 2014/15 to 8-9%. The EBIT margin is still expected to be above 26.5%, while free cash flow is now expected to be around EUR 150 million.

Chr. Hansen Holding A/S, Q3 2015 Earnings Call, Jul 01, 2015

Chr. Hansen Holding A/S, Q3 2015 Earnings Call, Jul 01, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CHR:DC kr375.00 DKK 0.00

CHR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Balchem Corp $56.09 USD -0.58
Corbion NV €19.67 EUR +0.485
Ebro Foods SA €18.81 EUR +0.63
Wessanen €10.10 EUR +0.325
Sensient Technologies Corp $68.20 USD -0.19
View Industry Companies
 

Industry Analysis

CHR

Industry Average

Valuation CHR Industry Range
Price/Earnings 43.7x
Price/Sales 7.9x
Price/Book 9.5x
Price/Cash Flow 44.3x
TEV/Sales 7.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHR HANSEN HOLDING A/S, please visit www.chr-hansen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.